Clinical Trials on Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) in Luxembourg
Total 2 results
-
Luxembourg Institute of HealthViewMindRecruiting
-
Luxembourg Institute of HealthCompletedCOVID-19 | Post-Acute COVID-19Luxembourg
Sponsors and Collaborators
- Korrus Inc.
- Ana Paula Costella
- Michael J. Wesley, PhD
- IRCCS Don Gnocchi, Milano, Italy
- Walgreens Co.
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Gulsah Ilhan
- Edanz Group Japan Ltd
- Pharmaspecific
- Center for Rare Neurological Diseases, Norcross, GA
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- HeartPoint Global
- Frankel, Amylynne, M.D.
- Ruba Musharbash Nutrition Consultancy Center
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Fundación Pública Andaluza Progreso y Salud
- Laboratorios Viñas, S.A.
- King Baudouin Foundation
- Army Hospital, Percy
- Manmohan Cardiothoracic Vascular and Transplant Center
- View Full List
Medical Conditions
- Severe Atopic Dermatitis
- Uncontrolled Type 2 Diabetes Mellitus
- Malignant Intracranial Germ Cell Tumor
- Localized Unresectable Adult Primary Liver Cancer
- Paralysis of Vocal Cords or Larynx
- Facial Involvement
- Developmental Language Disorder and Language Impairment
- Ankylosed Teeth
- Brain Arteriovenous Malformation
- Kidney Damage
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Cognitive Function, Social 1
- Impairment, Coordination
- Menopause
- Cardiovascular Outcomes
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Lung Neuroendocrine Tumor
- Gastroenteritis Rotavirus
- Pelvis Tumors
- Coagulation Disorder Neonatal
- View Full List
Drug Interventions
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Apremilast
- Dexmedetomidine
- Methotrexate
- Transdermal estradiol
- Thiotepa
- Extended release guanfacine
- Lidocaine/ ketamine
- Miglustat
- LDEPA
- Ozanimod
- Exendin 9-39
- Interleukin-2
- Insulin
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- 5-Fluorouracil
- CD25 treatment
- FHND5071
- Interferon beta-1b (Betaferon, BAY86-5046)
- Rituximab plus CHOP
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Moldova
- Contract Research Organizations in Philippines
- Contract Research Organizations in South Africa
- CRO list by country